homocysteine has been researched along with Ventricular Dysfunction, Left in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 7 (36.84) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, C; Gao, Y; Wang, Q; Xia, H | 1 |
| Abdelhamid, A; Farghaly, HS; Metwalley, KA | 1 |
| Douzis, ICh; Karkalousos, PL; Lazaris, AC; Liapi, CA; Mourouzis, IS; Pantos, CI; Perelas, AI; Strilakou, AA; Stylianaki, AT | 1 |
| Huang, J; Li, Y; Luo, M; Xie, N; Xu, H; Zheng, H | 1 |
| Jiahong, X; Jinfa, J; Ruhui, L; Wenlin, M | 1 |
| Li, Y; Lou, T; Ma, X; Peng, H; Wang, C; Ye, Z; Zhang, J; Zhang, Q | 1 |
| Van Wagoner, DR | 1 |
| Eren, M; Kucukoglu, S; Mutlu, H; Nurkalem, Z; Okcun, B; Okuyan, E; Orhan, AL; Sayar, N; Soylu, O; Uslu, N; Yildiz, A | 1 |
| Bayindir, O; Görmüş, U; Mutaf, I; Ozdoğan, O; Ozmen, B; Ozmen, D; Parildar, Z | 1 |
| Gargoum, R; Maldonado, C; Metreveli, N; Rosenberger, D; Sen, U; Tyagi, N; Tyagi, S | 1 |
| de Faire, U; Frostegård, J; Hamsten, A; Jensen-Urstad, K; Silveira, A; Svenungsson, E; Witztum, JL | 1 |
| Blann, A; Lip, GY; Nadar, S | 1 |
| Karpiński, M; Kiryłów, E; Kosior, J; Kubik, L; Orski, Z; Parol, G; Pecak, R | 1 |
| Benjamin, EJ; D'Agostino, RB; Jacques, PF; Levy, D; Rosenberg, IH; Selhub, J; Sullivan, L; Sundström, J; Vasan, RS; Wilson, PW | 1 |
| Bokhari, SW; Bokhari, ZW; Faxon, DP; Lee, DW; Zell, JA | 1 |
| Lucchesi, PA; Rezk, B; Rocic, P | 1 |
| Alharethi, R; Anderson, JL; Bair, TL; Carlquist, JF; Horne, BD; Kfoury, AG; May, HT; Muhlestein, JB; Renlund, DG; Reyna, SP | 1 |
| Głuszek, J; Pawlak, AL; Strauss, E; Supiński, W | 1 |
| Abdelmouttaleb, I; Aliot, E; Danchin, N; Guéant, JL; Guéant-Rodriguez, RM; Herbeth, B; Juillière, Y; Nippert, M | 1 |
19 other study(ies) available for homocysteine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Elevated Plasma Homocysteine Level Associated with Further Left Ventricular Structure and Function Damages in Type 2 Diabetic Patients: A Three-Dimensional Speckle Tracking Echocardiography Study.
Topics: Aged; Diabetes Mellitus, Type 2; Echocardiography; Female; Heart Ventricles; Homocysteine; Humans; Hyperhomocysteinemia; Imaging, Three-Dimensional; Male; Middle Aged; Ventricular Dysfunction, Left; Ventricular Remodeling | 2021 |
Homocysteine Level in Children with Classic Congenital Adrenal Hyperplasia: Relationship to Carotid Intimal Wall Thickness and Left Ventricular Function.
Topics: Adrenal Hyperplasia, Congenital; Carotid Intima-Media Thickness; Child; Child, Preschool; Cross-Sectional Studies; Female; Homocysteine; Humans; Male; Ultrasonography, Doppler, Duplex; Ventricular Dysfunction, Left; Ventricular Function, Left | 2018 |
Heart dysfunction induced by choline-deficiency in adult rats: the protective role of L-carnitine.
Topics: Animals; Cardiotonic Agents; Carnitine; Choline Deficiency; Dietary Supplements; Edema, Cardiac; Fibrosis; Heart Valves; Heart Ventricles; Homocysteine; Hyperhomocysteinemia; Lymphocytes; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Random Allocation; Rats; Rats, Wistar; Ventricular Dysfunction, Left | 2013 |
Echocardiographic assessment of hypertensive patients with or without hyperhomocysteinemia.
Topics: Adult; Aged; Diastole; Echocardiography; Female; Heart Ventricles; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Male; Middle Aged; Ventricular Dysfunction, Left; Ventricular Function, Left | 2014 |
Influence of hyperhomocysteinemia on left ventricular diastolic function in Chinese patients with hypertension.
Topics: Biomarkers; Causality; China; Comorbidity; Cross-Sectional Studies; Female; Homocysteine; Humans; Hyperhomocysteinemia; Hypertension; Incidence; Male; Middle Aged; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2015 |
High Prevalence of Hyperhomocysteinemia and Its Association with Target Organ Damage in Chinese Patients with Chronic Kidney Disease.
Topics: Adult; Calcium Phosphates; Carotid Arteries; Carotid Intima-Media Thickness; Cross-Sectional Studies; Female; Glomerular Filtration Rate; Hemoglobins; Homocysteine; Humans; Hyperhomocysteinemia; Hypertrophy, Left Ventricular; Incidence; Kidney; Linear Models; Male; Middle Aged; Prevalence; Renal Insufficiency, Chronic; Risk Factors; Serum Albumin; Sex Factors; Uric Acid; Ventricular Dysfunction, Left | 2016 |
Is homocysteine a mediator of atrial dysfunction or just another marker of endothelial dysfunction?
Topics: Atrial Fibrillation; Biomarkers; Coronary Artery Disease; Endothelium, Vascular; Homocysteine; Humans; Ventricular Dysfunction, Left | 2008 |
Plasma homocysteine level and left ventricular thrombus formation in acute anterior myocardial infarction patients following thrombolytic therapy with t-PA.
Topics: Adult; Echocardiography; Fasting; Female; Fibrinolytic Agents; Heart Ventricles; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Thrombolytic Therapy; Thrombosis; Tissue Plasminogen Activator; Ventricular Dysfunction, Left | 2009 |
Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction.
Topics: Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diastole; Echocardiography; Echocardiography, Transesophageal; Female; Homocysteine; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Ventricular Dysfunction, Left; Ventricular Function, Left | 2010 |
Homocysteine enriched diet leads to prolonged QT interval and reduced left ventricular performance in telemetric monitored mice.
Topics: Animals; Arrhythmias, Cardiac; Cardiovascular Diseases; Connexins; Diet; Disease Models, Animal; Echocardiography; Heart Ventricles; Homocysteine; Hyperhomocysteinemia; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Neural Conduction; Random Allocation; Telemetry; Ventricular Dysfunction, Left; Ventricular Remodeling | 2011 |
Cardiac valvular abnormalities are frequent in systemic lupus erythematosus patients with manifest arterial disease.
Topics: Acute-Phase Reaction; Adult; Arteriosclerosis; Autoantibodies; Cholesterol; Cohort Studies; Echocardiography; Female; Heart Valve Diseases; Homocysteine; Humans; Hypertension, Pulmonary; Lipoproteins, LDL; Lupus Erythematosus, Systemic; Middle Aged; Risk Factors; Triglycerides; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2002 |
Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
Topics: Adult; Age Factors; Aged; Atrial Fibrillation; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Middle Aged; Risk; Thromboembolism; Thrombophilia; Ventricular Dysfunction, Left | 2003 |
[Diagnostic and prognostic significance of homocysteine determined in acute phase of myocardial infarction].
Topics: Adult; Aged; Exercise Test; Female; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Prognosis; Ventricular Dysfunction, Left | 2003 |
Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study.
Topics: Cardiac Volume; Female; Homocysteine; Humans; Hyperhomocysteinemia; Longitudinal Studies; Male; Middle Aged; Sex Characteristics; Ventricular Dysfunction, Left; Ventricular Remodeling | 2004 |
Plasma homocysteine levels and the left ventricular systolic function in coronary artery disease patients.
Topics: Aged; Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 1; Female; Homocysteine; Humans; Hyperhomocysteinemia; Male; Multivariate Analysis; Racial Groups; Severity of Illness Index; Stroke Volume; Systole; Ventricular Dysfunction, Left | 2005 |
PPAR-gamma agonists decrease hyperhomcysteinemia and cardiac dysfunction: new hope for ailing diabetic hearts?
Topics: Animals; Cardiotonic Agents; Diabetes Complications; Homocysteine; Hyperhomocysteinemia; Mice; PPAR gamma; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Homocysteine levels are associated with increased risk of congestive heart failure in patients with and without coronary artery disease.
Topics: Aged; Coronary Artery Disease; Female; Heart Failure; Homocysteine; Humans; Male; Middle Aged; Stroke Volume; Ventricular Dysfunction, Left | 2007 |
[In patients with coronary artery disease and left ventricular contractile insufficiency the pathogenicity of smoking associates with imbalance in metabolism of homocysteine].
Topics: Adult; Comorbidity; Coronary Angiography; Coronary Artery Disease; Folic Acid; Homocysteine; Humans; Male; Middle Aged; Myocardial Infarction; Smoking; Stroke Volume; Ventricular Dysfunction, Left | 2006 |
Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions.
Topics: Aged; Angiography; Coronary Artery Disease; Female; Homocysteine; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Stroke Volume; Systole; Ventricular Dysfunction, Left | 2007 |